Blueprint Medicines Corp
2019 Q4 - 2025 Q2 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q2 | 7/29/2025 | 4,300 | 0.0% | 33,547 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 3,055 | 0.0% | 34,521 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 2,801 | 0.0% | 32,116 | 12/31/2024 |
| 2024 Q3 | 11/6/2024 | 2,973 | 0.0% | 32,144 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 3,497 | 0.0% | 32,446 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 3,211 | 0.0% | 33,850 | 3/31/2024 |
| 2023 Q4 | 1/26/2024 | 3,376 | 0.0% | 36,602 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 1,577 | 0.0% | 31,398 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 2,103 | 0.0% | 33,269 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 1,611 | 0.0% | 35,811 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 1,641 | 0.0% | 37,462 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 2,435 | 0.0% | 36,951 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 2,036 | 0.0% | 40,313 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 2,594 | 0.0% | 40,615 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 4,539 | 0.0% | 42,378 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 4,397 | 0.0% | 42,773 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 3,816 | 0.0% | 43,388 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 4,400 | 0.0% | 45,255 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 5,356 | 0.1% | 47,758 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 4,520 | 0.1% | 48,761 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 3,042 | 0.0% | 39,006 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 2,470 | 0.0% | 42,243 | 3/31/2020 |
| 2019 Q4 | 2/11/2020 | 3,531 | 0.0% | 44,075 | 12/31/2019 |